Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya-Reference-Cited by-同舟云学术

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya

Published:2017-08-04 Issue:1 Volume:45 Page:
ISSN:1349-4147
Container-title:Tropical Medicine and Health
language:en
Short-container-title:Trop Med Health

Author:

Sawe Rispah T.,Mining Simeon K.,Ofulla Ayub V.,Patel Kirtika,Guyah Bernard,Chumba David,Prosperi Jenifer R.,Kerper Maggie,Shi Zonggao,Sandoval-Cooper Mayra,Taylor Katherine,Badve Sunil,Stack M. Sharon,Littlepage Laurie E.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/s41182-017-0059-4.pdf

Reference32 articles.

1. Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F, Rouas G, Francis P, Crown JP, Hitre E, De Azambuja E. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. J Clin Oncol. 2013;31(7):860–7.

2. Denkert C, Huober J, Loibl S, Prinzler J, Kronenwett R, Darb-Esfahani S, Brase JC, Solbach C, Mehta K, Fasching PA, Sinn BV. HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer. Breast Cancer Res. 2013;15(1):R11.

3. Krell J, Frampton AE, Stebbing J. The clinical significance of tumor infiltrating lymphocytes in breast cancer: does subtype matter? BMC Cancer. 2012;12(1):135.

4. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–4.

5. DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, Rugo HS. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011;1(1):54–67.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics;Breast Cancer Research and Treatment;2023-04-03

2. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women;BMC Women's Health;2021-12

3. In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review;Translational Oncology;2021-05

4. Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis;JCO Global Oncology;2021-02

5. Meta-analysis of NFKB1-94 ATTG Ins/Del Polymorphism and Risk of Breast Cancer;Current Drug Metabolism;2020-06-25